4981 - 4990 of 6564 Results
Title
Year
-
OPENTitle: A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 24End Page: 24Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00370-yBest OA location URL: https://hdl.handle.net/11384/134323Citation Count: 28
-
OPENTitle: Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degenerationJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 26Issue #: 3Start Page: 387End Page: 397Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-020-0762-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7101073Citation Count: 802
-
OPENTitle: Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 102Issue #: 4Start Page: e208033End Page: e208033Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000208033Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11383879/pdf/WNL-2023-001997.pdfCitation Count: 22
-
OPENTitle: Nova-ST: Nano-patterned ultra-dense platform for spatial transcriptomicsJournal Name: Cell Reports MethodsPublisher: Elsevier BVVol: 4Issue #: 8Start Page: 100831End Page: 100831Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100831Best OA location URL: https://doi.org/10.1016/j.crmeth.2024.100831Citation Count: 28
-
OPENTitle: Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic SignalingJournal Name: Molecular CellPublisher: Elsevier BVVol: 77Issue #: 5Start Page: 1124End Page: 1142.e10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.molcel.2019.11.013Best OA location URL: https://doi.org/10.1016/j.molcel.2019.11.013Citation Count: 224
-
OPENTitle: Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S PatientsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 526End Page: 526Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00526Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00526/pdfCitation Count: 34
-
OPENTitle: Multiple sclerosis in LRRK2 G2019S Parkinson’s disease and isolated nigral degeneration in a homozygous variant carrierJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page: 1450654End Page: 1450654Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2024.1450654Best OA location URL: https://doi.org/10.3389/fneur.2024.1450654Citation Count: 3
-
OPENTitle: Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page: 15End Page: 20Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-019-0556-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7257994Citation Count: 184
-
OPENTitle: LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived NeuronsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 442End Page: 442Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00442Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00442/pdfCitation Count: 57
-
OPENTitle: EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 543End Page: 558Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191841Best OA location URL: https://escholarship.org/uc/item/1vs1b0ctCitation Count: 36